Related Experiment Videos
Lung proteome alterations in a mouse model for nonallergic asthma
René Houtman1, Jeroen Krijgsveld, Mirjam Kool
1Department of Pharmaceutical Proteomics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. r.houtmann@pharm.uu.nl
Proteomics
|November 20, 2003
Summary
This study used proteomics to identify 23 altered proteins in a mouse model of nonatopic asthma. These proteins may serve as biomarkers for monitoring asthma progression and therapeutic response.
Area of Science:
- Proteomics
- Biochemistry
- Immunology
Background:
- Nonatopic asthma pathophysiology involves complex molecular mechanisms.
- Understanding these mechanisms requires advanced analytical techniques.
Purpose of the Study:
- To investigate lung proteome alterations in a mouse model of nonatopic asthma.
- To identify potential protein biomarkers for disease monitoring and therapeutic response.
Main Methods:
- Utilized a mouse model of nonatopic asthma induced by hapten challenge.
- Employed two-dimensional gel electrophoresis and mass spectrometry to analyze lung proteomes.
- Examined 2115 proteins for differential expression in asthmatic versus control mice.
Main Results:
- Identified 23 significantly up- or down-regulated proteins in asthmatic mouse lungs.
- Identified 20 proteins by mass spectrometry, with 18 linked to asthma symptoms like inflammation and tissue remodeling.
- Demonstrated proteomics as a valuable tool for studying complex diseases like asthma.
Conclusions:
- Proteomic analysis revealed key proteins associated with asthma pathophysiology.
- Identified proteins may serve as surrogate biomarkers for disease state and treatment efficacy.
- Highlights the need for high replicate numbers in proteomic studies for statistical confidence.